Paroxetine
Paroxetine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Paroxetine; Generic name: PAROXETINE; Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs.
| Brand name | Paroxetine |
|---|---|
| Generic name | PAROXETINE |
| Manufacturer | NCS HealthCare of KY, LLC dba Vangard Labs |
| Used for | INDICATIONS AND USAGE Major Depressive Disorder Paroxetine tablets, USP are indicated for the treatment of major depressive disorder. The efficacy of paroxetine in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the DSM-III category of major depressive disorder (see CLINICAL PHARMACOLOGY: Clinical Trials ). A major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: Change in appetite, change in sleep, psychom |
| Dosage | DOSAGE AND ADMINISTRATION Major Depressive Disorder Usual Initial Dosage Paroxetine tablets, USP should be administered as a single daily dose with or without food, usually in the morning. The recommended initial dose is 20 mg/day. Patients were dosed in a range of 20 to 50 mg/day in the clinical trials demonstrating the effectiveness of paroxetine tablets, USP in the treatment of major depressive disorder. As with all drugs effective in the treatment of major depressive disorder, the full effec |
| Warnings | WARNINGS Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are t |
| Active ingredient(s) | PAROXETINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a8a58c7-5008-4c65-ae0e-e4ee809b1807 |